# Observational atherosclerosis studies recruiting: 70 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 70 trials that are observational for atherosclerosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational atherosclerosis studies: 70 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/atherosclerosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 70
- Recruiting or not yet: 70
- Read on: November 19, 2026

## Trials

The 25 newest of 70, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07916883 | PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite) | Washington University School of Medicine | Observational | Recruiting | Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic, Asymptomatic Carotid Artery Stenosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916883) |
| October 8, 2026 | NCT07865884 | Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens | Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital | Observational | Not yet recruiting | Breast Cancer, Vascular Calcification, Coronary Artery Calcification, Atherosclerosis Cardiovascular Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07865884) |
| October 2, 2026 | NCT07856264 | PCSK9 Inhibitors in Hyperlipidemia and Atherosclerosis | Fundación Santa Fe de Bogota | Observational | Not yet recruiting | Hyperlipidemia, Atherosclerotic Cardiovascular Disease (ASCVD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856264) |
| August 21, 2026 | NCT07780552 | CHIP in Health and Disease | VASCage GmbH | Observational | Not yet recruiting | Clonal Hematopoiesis, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780552) |
| August 19, 2026 | NCT07772466 | Atherosclerosis in Early Rheumatoid Arthritis Patients Using Atherogenic Index of the Plasma and Carotid Intima Media Thickness | Assiut University | Observational | Not yet recruiting | Atheroscleroses, Rheumatoid Arthritis (RA | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772466) |
| August 14, 2026 | NCT07765797 | Development and Validation of a Scale of Propensity for Change in Chronic Disease Prevention | University Hospital, Toulouse | Observational | Recruiting | Atheroscleroses, Geriatric | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07765797) |
| August 3, 2026 | NCT07743021 | Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data | Center for Molecular Fingerprinting Research Nonprofit LLC | Observational | Recruiting | Non-communicable Diseases (NCD), Neoplams, Cancer, Lung Cancer (NSCLC), Cardiovascular Diseases (CVD), Atherosclerotic... | 15,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743021) |
| June 30, 2026 | NCT07675928 | Qatar Cardiometabolic Cohort | Weill Cornell Medical College in Qatar | Observational | Not yet recruiting | Cardiometabolic Diseases | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07675928) |
| May 18, 2026 | NCT07594392 | Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE | St. Jude Children's Research Hospital | Observational | Recruiting | Atherosclerotic Cardiovascular Disease | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07594392) |
| April 30, 2026 | NCT07558239 | Carotid Intima-media Thickness in Dialysis Patients and Traditional Risk Factors | Minia University | Observational | Not yet recruiting | Dialysis Patients, Hypertension, Atherosclerosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558239) |
| April 22, 2026 | NCT07545408 | Subclinical Atherosclerosis in Juvenile Systemic Lupus Erythematosus | Assiut University | Observational | Not yet recruiting | Atherosclerosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07545408) |
| April 22, 2026 | NCT07543731 | A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab | Novartis Pharmaceuticals | Observational | Recruiting | Cardiovascular Diseases, Atherosclerotic Cardiovascular Disease, Hypercholesterolemia, Familial | 5,995 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543731) |
| April 21, 2026 | NCT07542860 | Aspirin 50 mg vs. 100 mg in Elderly Cardiovascular Disease Patients | Peking University First Hospital | Observational | Recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Secondary Prevention, Cardiovascular Diseases | 5,448 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07542860) |
| April 9, 2026 | NCT07520643 | MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Subclinical Atherosclerotic Cardiovascular Disease, Neurocognitive Decline | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07520643) |
| March 16, 2026 | NCT07474233 | Associations Between Dietary Patterns, LDL Aggregation, and Cardiometabolic Health | Liverpool John Moores University | Observational | Not yet recruiting | Atherosclerosis Cardiovascular Disease, Metabolic Syndrome, Dyslipidaemia, Endothelial Dysfunction | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07474233) |
| March 3, 2026 | NCT07447648 | Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque... | Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | Observational | Recruiting | Homozygous Familial Hypercholesterolemia (HoFH), Coronary Computed Tomography Angiography | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07447648) |
| February 17, 2026 | NCT07412457 | Guideline Adherence in Dyslipidemia With Clinical Decision Support | I.M. Sechenov First Moscow State Medical University | Observational | Not yet recruiting | Dyslipidemia, Coronary Artery Disease, Atherosclerosis of Major Arteries, Cardiovascular Risk, Subclinical... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07412457) |
| February 6, 2026 | NCT07394400 | Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults. | Sponsor not shown (see the record) | Observational | Not yet recruiting | Transgender Individuals | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07394400) |
| February 2, 2026 | NCT07380828 | CArdio-Reno- Hepato -MEtabolic Disease iN Chronic Heart Failure (CARMEN-CHF) | Russian Scientific Medical Society of Therapists | Observational | Not yet recruiting | Heart Failure, Cardio-renal-metabolic Syndrome | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07380828) |
| January 23, 2026 | NCT07364058 | Assessment of Platelet-derived GARP in Atherosclerotic Disease | Université Catholique de Louvain | Observational | Not yet recruiting | Atheroma; Carotid Artery, Atheromatosis | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07364058) |
| January 5, 2026 | NCT07315997 | The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study | Brigham and Women's Hospital | Observational | Recruiting | Rheumatoid Arthritis (RA, Atherosclerotic Cardiovascular Disease (ASCVD) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07315997) |
| December 22, 2025 | NCT07296965 | Oral Microbiome in Carotid Atherosclerosis | Semmelweis University Heart and Vascular Center | Observational | Recruiting | Atherosclerosis Cardiovascular Disease, Atherosclerosis of Artery, Carotid Artery Plaque, Periodontitis, Carotid Artery... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07296965) |
| December 5, 2025 | NCT07266220 | Carotid Doppler Screening for Subclinical Atherosclerosis in Diabetic CKD Patients. | Sponsor not shown (see the record) | Observational | Not yet recruiting | Diabetes Mellitus, Type 2, Chronic Kidney Disease, Atherosclerosis | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266220) |
| October 6, 2025 | NCT07208331 | Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Observational | Recruiting | Atherosclerotic Cardiovascular Disease (ASCVD), Hypertension, Dyslipidemia | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07208331) |
| August 21, 2025 | NCT07134166 | Cardiac Imaging in Systemic Disorders: the ORACLES Registry | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Lupus | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07134166) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| Chinese University of Hong Kong | 3 |
| University Hospital, Toulouse | 2 |
| Semmelweis University Heart and Vascular Center | 2 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| University Hospital, Grenoble | 2 |
| Assiut University | 2 |
| Université Catholique de Louvain | 1 |
| Fundación Santa Fe de Bogota | 1 |
| Azienda Ospedaliero-Universitaria di Parma | 1 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 1 |
| Instituto de Investigación Biomédica de Salamanca | 1 |
| Center for Molecular Fingerprinting Research Nonprofit LLC | 1 |
| IRCCS SYNLAB SDN | 1 |
| Queen Mary University of London | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Brigham and Women's Hospital | 1 |
| Bangladesh University of Engineering and Technology | 1 |
| Xuanwu Hospital, Beijing | 1 |
| I.M. Sechenov First Moscow State Medical University | 1 |
| Peking University First Hospital | 1 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 1 |
| Austral University, Argentina | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 8 |
| Netherlands | 7 |
| France | 6 |
| Italy | 5 |
| United Kingdom | 4 |
| China | 4 |
| Hungary | 3 |
| Spain | 3 |
| Hong Kong | 3 |
| Russia | 3 |
| Canada | 2 |
| Sweden | 2 |
| Brazil | 2 |
| Belgium | 1 |
| Turkey (Türkiye) | 1 |
| Bangladesh | 1 |
| Switzerland | 1 |
| Argentina | 1 |
| Germany | 1 |
| Pakistan | 1 |
| Japan | 1 |
| Qatar | 1 |
| South Korea | 1 |
| Latvia | 1 |
| Austria | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [French restaurants in the United States](https://specstream.ai/data/businesses/french-restaurants/united-states)
- [Private equity firms in the United States](https://specstream.ai/data/businesses/private-equity-firms/united-states)
- [B2B industrial and machine companies in the United States](https://specstream.ai/data/businesses/b2b-industrial-and-machine-companies/united-states)
- [Gastropubs in the United States](https://specstream.ai/data/businesses/gastropubs/united-states)
- [Promotional products companies in the United States](https://specstream.ai/data/businesses/promotional-products-companies/united-states)
- [B2B oil and gas equipment companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-equipment-companies/united-states)
